SYNCOMF

HealthcareDrug Manufacturers - Specialty & GenericSmall Cap
Syncom Formulations (India) Limited

Syncom Formulations (India) Limited operates in the Healthcare sector, specifically as a Drug Manufacturer - Specialty & Generic. The company manufactures, markets, and sells pharm...

हिन्दी में

Syncom Formulations (India) Limited हेल्थकेयर सेक्टर में काम करती है, विशेष रूप से एक ड्रग मैन्युफैक्चरर - स्पेशलिटी और जेनेरिक के तौर पर। यह कंपनी भारत और अंतरराष्ट्रीय स्तर पर फा...

₹23.28-1.23%1D
Previous trading day close · Data updates after market close
1W: +0.6%
1M: +15.6%
6M: +74.1%
1Y: +42.3%
78/100
GoodResearch Score
Market Cap
₹1.3K Cr
Small Cap
P/E Ratio
17.70
Below avg
P/B Ratio
3.95
Premium
ROE
15.7%
Decent
ROCE
28.9%
Excellent
Debt / Equity
0.01
Low debt
Div. Yield
N/A
EV/EBITDA
11.65
Attractive
52W Low: ₹10.21Current: ₹23.2852W High: ₹27.49
At 76% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
80/100
Growth
Revenue, EPS, profit growth
100/100
Valuation
PE, PB, EV/EBITDA vs sector
65/100
Risk
Debt levels, volatility, coverage
74/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
17.70(Below avg)
Forward P/E
N/A
P/B Ratio
3.95(Premium)
P/S Ratio
2.60(Good)
EV/EBITDA
11.65(Attractive)
Dividend Yield
N/A
5Y CAGR
N/A
Revenue Growth
7.9%(Moderate)
Profitability
ROE
15.7%(Good)
ROCE
28.9%(Excellent)
ROA
12.1%(Efficient)
Net Margin
14.7%(Decent)
EBITDA Margin
20.9%
Financial Health
Debt to Equity
0.01(Low debt)
Current Ratio
4.55(Healthy)
Quick Ratio
3.85(Good)
Interest Coverage
88.17x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
62(Neutral)
RSI Exp (14)
63(Neutral)
MACD
1.547(Bullish)
MACD Signal
1.510
BB Position
68%(Middle)
BB Width
45.47%(High volatility)
ADX (14)
32.5(Strong trend)
Williams %R
-53.4(Neutral)
MFI (14)
81(Overbought)
CCI (20)
53(Neutral)
Stoch %K
47(Neutral)
ATR (14)
1.97(Avg True Range)
OBV (M)
402.0(Positive)
1W OBV Chg
1.7%(Increasing)
Rel Volume
0.91x(Normal)
Volatility
46.1%(High)
Max DD 1Y
-56.4%(High loss)
EMA 200
16.3
EMA 50
19.5
SMA 200
14.8
vs SMA 50
25.4%(Above SMA50)
vs SMA 200
57.7%(Above SMA200)
Volume
1.49Cr
Avg Vol 3M
162.7L
Shareholding Pattern
Promoter
50.6%
High confidence
FII
0.2%
DII / MF
0.0%
Share SYNCOMF
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.